AhR activation seems to be responsible, at least in part, for endothelial dysfunction in patients with CKD since uremic toxins such as IS and IAA, as AhR agonists lead to increased oxidative stress and vascular inflammation. The gene discussed is AHR; the disease is endothelial dysfunction.